Neb. man sues makers of Rituxan after infection - The Associated Press

Neb. man sues makers of Rituxan after infection The Associated Press Rituxan, according to the drug's website, is approved to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia and rheumatoid arthritis. ... and more »

Biogen faces lawsuit over drug safety - Boston Business Journal

Biogen faces lawsuit over drug safety Boston Business Journal Rituxan is approved for the treatment of non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia and Rheumatoid Arthritis. Peetz was taking the medication for ... and more »

Inspire Names Dr. Charles Johnson as Executive Vice President of Research and ... - MarketWatch (press release)

Inspire Names Dr. Charles Johnson as Executive Vice President of Research and ... MarketWatch (press release) ... with responsibility for the approvals of RITUXAN(R) for rheumatoid arthritis and LUCENTIS(R) for wet age-related macular degeneration and for the ... and more »

Trubion Pharmaceuticals Gets Acquired by Emergent BioSolutions for M Upfront - Xconomy

Trubion Pharmaceuticals Gets Acquired by Emergent BioSolutions for M Upfront Xconomy ... for rheumatoid arthritis patients than an already approved drug that hits the same target on cells, Genentech and Biogen Idec's rituximab (Rituxan). ... and more »